Aier Ophthalmology has once again been listed as one of the "Top 500 Chinese New Economy Enterprises"

Recently, the China Enterprise Evaluation Association, together with the China Index Research Institute, officially released the "2025 China New Economy Enterprise TOP500 Development Report" and a series of rankings in Beijing, and pointed out that "the focus of competition in the new economy is shifting from traffic driven to innovation driven". Aier Eye Hospital Group Co., Ltd. (hereinafter referred to as "Aier Eye") has been ranked 69th on the "China's Top 500 New Economy Enterprises" list for five consecutive years, thanks to its solid innovative practices and outstanding development achievements. Its ranking has increased by 4 places compared to last year, demonstrating strong development resilience.

This is the sixth consecutive year that the TOP500 report and list of China's new economy have been released, presenting the development pattern, growth momentum, and evolution trend of China's new economy enterprises. This evaluation selected over 5000 evaluation sample pools from more than 15000 market entities, with the market/valuation as the main sequence indicator as of June 30, 2025. Seven major categories and 15 sub correction indicators were set, including enterprise size, profitability, growth rate, innovation driven, social contribution, social impact, and internationalization level. The weight of the innovation driven indicator was as high as 25%.

Having been deeply involved in the eye health industry for over 20 years, Aier Ophthalmology adheres to the strategic core of "innovation driven, technological Aier", and develops comprehensively in multiple fields including medicine, education, research, production, and investment to meet the growing eye health needs of patients.

In terms of model innovation, Aier Eye Hospital has explored and established a hierarchical chain model of "flagship hospital in central cities provincial capital city hospitals prefecture level city hospitals county-level hospitals" based on the current situation of China's ophthalmic medical service industry, achieving efficient sinking and sharing of high-quality ophthalmic medical resources, solving the problem of uneven distribution of medical resources, and enabling patients in remote areas to conveniently enjoy high-level diagnosis and treatment services.

In the field of technological innovation, Aier Ophthalmology continues to increase research and development investment, fully supporting cutting-edge and original ophthalmic academic research, and actively promoting the implementation of the global eye health ecosystem strategy. At present, an integrated innovation platform system for medical research and teaching has been established, consisting of "multiple hospitals, multiple institutes, five stations, five centers, four bases, one platform, and one office", achieving full chain talent cultivation and incubation from undergraduate to postdoctoral. In recent years, Aier Ophthalmology has closely followed the development trend of the industry, launched the "Digital Ophthalmology" model, and continuously improved the intelligence level of medical services by using new technologies, models, and platforms. It has gradually built an eye health service system that covers the entire life cycle of users and a full service platform, effectively improving hospital operation efficiency and patient medical experience, promoting the extension of high-quality diagnosis and treatment resources to the grassroots level, and clearing the bottlenecks, blockages, and difficulties of patient medical treatment, becoming a benchmark example of the integration of data and practice in the medical field.

In terms of innovative public welfare practices, Aier Eye Hospital adopts a "cross subsidy" public welfare model, fully leveraging its advantages in talent, technology, resources, and other aspects to create a sustainable public welfare model, demonstrating its responsibility as a corporate citizen. As of now, Aier Ophthalmology has supported 873 public welfare projects, with a public welfare footprint covering more than 300 regions in 31 provinces, municipalities, and autonomous regions across the country. It has won the "China Charity Award" for three consecutive years, fulfilling its original mission of "enabling everyone, regardless of poverty or wealth, to enjoy the right to eye health" through practical actions.

In the future, Aier Ophthalmology will continue to be guided by the concept of high-quality development, empower the development of eye health with innovation, assist in the construction of a healthy China, and contribute more to improving China's ophthalmic medical technology and promoting the progress of human ophthalmology and visual science.